We are live on
!
Find out more
HA
Hamel Associates Portfolio holdings
AUM
$363M
1-Year Est. Return
24.39%
This Fund
S&P 500
This Quarter
Est. Return
+1.52%
1 Year Est. Return
+24.39%
3 Year Est. Return
+50.64%
5 Year Est. Return
+68.03%
10 Year Est. Return
+174.56%
AUM
$295M
AUM Growth
+$1.04M
(+0.35%)
Cap. Flow
+$1.16M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
40.24%
Holding
82
New
11
Increased
15
Reduced
41
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Dividend Equity ETF
SCHY
|
+$10.2M |
| 2 |
Huntington Ingalls Industries
HII
|
+$752K |
| 3 |
Merck
MRK
|
+$582K |
| 4 |
Amgen
AMGN
|
+$527K |
| 5 |
Duke Energy
DUK
|
+$511K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$3.7M |
| 2 |
Campbell Soup
CPB
|
+$2.85M |
| 3 |
General Mills
GIS
|
+$1.23M |
| 4 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$1.16M |
| 5 |
Starbucks
SBUX
|
+$629K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 13.89% |
| 2 | Technology | 11.81% |
| 3 | Healthcare | 11.44% |
| 4 | Financials | 10.06% |
| 5 | Industrials | 9.8% |
Similar funds
VIA
RC
MS
WI
HS
MA
SIAG
BHBT
Hamel Associates's Q2 2025 Portfolio in Review
As of Q2 2025, Hamel Associates held 82 positions worth $295M, up 0.35% from $294M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Hamel Associates's Q2 2025 filing shows 11 new, 15 increased, 41 reduced and 1 closed positions. Its largest new stake was Huntington Ingalls Industries: 3,366 shares worth $813K. The largest sale was Nike, an estimated $3.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- Hamel Associates's largest Q2 2025 buy was Huntington Ingalls Industries: 3,366 shares worth $813K.
- Hamel Associates added most to Schwab International Dividend Equity ETF in Q2 2025, an estimated $10.2M increase.
- Hamel Associates's biggest Q2 2025 reduction was Nike, cutting an estimated $3.7M.
- Hamel Associates fully exited Bristol-Myers Squibb in Q2 2025, selling an estimated $220K.
- Hamel Associates's ten largest holdings make up 40% of its $295M portfolio in Q2 2025.
- Hamel Associates opened 11 new positions and closed 1 in Q2 2025.
- Hamel Associates's portfolio value rose 0.35% quarter-over-quarter to $295M.
Based on Hamel Associates's 13F filing for Q2 2025, filed 13 Aug 2025.